Encompass Health Co. (NYSE:EHC) Shares Acquired by Tectonic Advisors LLC

Tectonic Advisors LLC lifted its stake in shares of Encompass Health Co. (NYSE:EHC) by 4.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,336 shares of the company’s stock after acquiring an additional 280 shares during the quarter. Tectonic Advisors LLC’s holdings in Encompass Health were worth $612,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the stock. International Assets Investment Management LLC acquired a new position in shares of Encompass Health during the third quarter valued at approximately $4,241,000. Sequoia Financial Advisors LLC bought a new stake in Encompass Health during the third quarter worth approximately $203,000. Copeland Capital Management LLC boosted its holdings in Encompass Health by 1.0% during the third quarter. Copeland Capital Management LLC now owns 1,284,550 shares of the company’s stock worth $124,139,000 after buying an additional 12,433 shares in the last quarter. Raymond James & Associates boosted its holdings in Encompass Health by 19.2% during the third quarter. Raymond James & Associates now owns 160,545 shares of the company’s stock worth $15,515,000 after buying an additional 25,907 shares in the last quarter. Finally, First Citizens Bank & Trust Co. bought a new stake in Encompass Health during the third quarter worth approximately $228,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on EHC shares. Barclays reduced their target price on shares of Encompass Health from $113.00 to $109.00 and set an “overweight” rating for the company in a report on Tuesday, August 6th. Leerink Partnrs upgraded shares of Encompass Health to a “strong-buy” rating in a report on Wednesday, July 10th. KeyCorp started coverage on shares of Encompass Health in a report on Friday, October 11th. They set an “overweight” rating and a $115.00 target price for the company. Leerink Partners started coverage on shares of Encompass Health in a research note on Wednesday, July 10th. They issued an “outperform” rating and a $100.00 price objective for the company. Finally, Royal Bank of Canada raised their price objective on shares of Encompass Health from $95.00 to $105.00 and gave the stock an “outperform” rating in a research note on Thursday, September 26th. Eight research analysts have rated the stock with a buy rating and three have issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $104.67.

Encompass Health Stock Down 1.3 %

EHC stock opened at $93.46 on Friday. Encompass Health Co. has a 12-month low of $57.55 and a 12-month high of $98.74. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.08. The company has a market cap of $9.40 billion, a price-to-earnings ratio of 23.84, a PEG ratio of 1.45 and a beta of 0.88. The company has a 50 day moving average of $93.58 and a two-hundred day moving average of $88.22.

Encompass Health (NYSE:EHC) last released its earnings results on Monday, August 5th. The company reported $1.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.01 by $0.10. Encompass Health had a net margin of 7.88% and a return on equity of 17.83%. The company had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.30 billion. During the same quarter in the prior year, the firm earned $0.95 EPS. The company’s revenue was up 9.6% compared to the same quarter last year. On average, equities analysts anticipate that Encompass Health Co. will post 4.18 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.73%. Encompass Health’s payout ratio is 17.35%.

Encompass Health declared that its board has authorized a share repurchase plan on Wednesday, July 24th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 5.4% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s management believes its shares are undervalued.

Insider Activity

In other news, CFO Douglas E. Coltharp sold 12,260 shares of the firm’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the transaction, the chief financial officer now owns 136,227 shares in the company, valued at approximately $11,761,839.18. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.10% of the stock is owned by insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.